Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon J Freeman

Showing results (101-110 of 348) with videos related to

Pageof 35
Sort By:
The Journal of Biological Chemistry|April 3, 2003
The BAL-binding protein BBAP and related Deltex family members exhibit ubiquitin-protein isopeptide ligase activityKunihiko Takeyama, Ricardo C T Aguiar, Liqun Gu, et al.
Mabs|August 4, 2022
An affinity threshold for maximum efficacy in anti-PD-1 immunotherapySarah C Cowles, Allison Sheen, Luciano Santollani, et al.
Communications Biology|March 19, 2020
Interaction of SHP-2 SH2 domains with PD-1 ITSM induces PD-1 dimerization and SHP-2 activationNikolaos Patsoukis, Jonathan S Duke-Cohan, Apoorvi Chaudhri, et al.
The Journal of Experimental Medicine|March 12, 2008
Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infectionSang-Jun Ha, Scott N Mueller, E John Wherry, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2003
Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine productionJulia A Brown, David M Dorfman, Feng-Rong Ma, et al.
Journal of Leukocyte Biology|February 27, 2013
Increased T-bet is associated with senescence of influenza virus-specific CD8 T cells in aged humansDouglas V Dolfi, Kathleen D Mansfield, Antonio M Polley, et al.
The Journal of Experimental Medicine|March 18, 2017
PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicityVikram R Juneja, Kathleen A McGuire, Robert T Manguso, et al.
Scientific Reports|January 11, 2018
Modeling tumor immunity of mouse glioblastoma by exhausted CD8<sup>+</sup> T cellsHiroshi Nakashima, Quazim A Alayo, Pablo Penaloza-MacMaster, et al.
Science Immunology|September 13, 2021
PD-1 blockade and vaccination provide therapeutic benefit against SIV by inducing broad and functional CD8<sup>+</sup> T cells in lymphoid tissueSheikh Abdul Rahman, Bhrugu Yagnik, Alexander P Bally, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 14, 2004
PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cellsYvette E Latchman, Spencer C Liang, Yin Wu, et al.
Pageof 35

Showing results (101-110 of 348) with videos related to

Sort By:
Pageof 35
The Journal of Biological Chemistry|April 3, 2003
The BAL-binding protein BBAP and related Deltex family members exhibit ubiquitin-protein isopeptide ligase activityKunihiko Takeyama, Ricardo C T Aguiar, Liqun Gu, et al.
Mabs|August 4, 2022
An affinity threshold for maximum efficacy in anti-PD-1 immunotherapySarah C Cowles, Allison Sheen, Luciano Santollani, et al.
Communications Biology|March 19, 2020
Interaction of SHP-2 SH2 domains with PD-1 ITSM induces PD-1 dimerization and SHP-2 activationNikolaos Patsoukis, Jonathan S Duke-Cohan, Apoorvi Chaudhri, et al.
The Journal of Experimental Medicine|March 12, 2008
Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infectionSang-Jun Ha, Scott N Mueller, E John Wherry, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2003
Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine productionJulia A Brown, David M Dorfman, Feng-Rong Ma, et al.
Journal of Leukocyte Biology|February 27, 2013
Increased T-bet is associated with senescence of influenza virus-specific CD8 T cells in aged humansDouglas V Dolfi, Kathleen D Mansfield, Antonio M Polley, et al.
The Journal of Experimental Medicine|March 18, 2017
PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicityVikram R Juneja, Kathleen A McGuire, Robert T Manguso, et al.
Scientific Reports|January 11, 2018
Modeling tumor immunity of mouse glioblastoma by exhausted CD8<sup>+</sup> T cellsHiroshi Nakashima, Quazim A Alayo, Pablo Penaloza-MacMaster, et al.
Science Immunology|September 13, 2021
PD-1 blockade and vaccination provide therapeutic benefit against SIV by inducing broad and functional CD8<sup>+</sup> T cells in lymphoid tissueSheikh Abdul Rahman, Bhrugu Yagnik, Alexander P Bally, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 14, 2004
PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cellsYvette E Latchman, Spencer C Liang, Yin Wu, et al.
Pageof 35